Related Articles
Consecutive salinomycin treatment reduces doxorubicin resistance of breast tumor cells by diminishing drug efflux pump expression and activity
Cucurbitacin B reverses multidrug resistance by targeting CIP2A to reactivate protein phosphatase 2A in MCF-7/adriamycin cells
Resveratrol reverses multidrug resistance in human breast cancer doxorubicin-resistant cells
The novel bis-benzylisoquinoline PY35 reverses P-glycoprotein-mediated multidrug resistance
Psoralen reverses the P-glycoprotein-mediated multidrug resistance in human breast cancer MCF-7/ADR cells